Vericel Corporation(VCEL)Earnings, Financials & Key Ratios

VCEL•NASDAQ

$36.78

$1.86B mkt cap·114.9× P/E·Price updated May 6, 2026

SectorHealthcare IndustryBiotechnology Sub-IndustryRegenerative Medicine and Tissue Engineering

AboutVericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.Show more

Revenue$276M+16.5%
EBITDA$3M-71.6%
Net Income$17M+59.4%
EPS (Diluted)0.32+60.0%
Gross Margin74.42%+2.6%
EBITDA Margin1.03%-75.6%
Operating Margin4%+109.9%
Net Margin5.98%+36.9%
ROE5.11%+27.7%
ROIC2.48%+105.6%
Debt/Equity0.27-19.8%

Technical→

VCEL Key Insights

Vericel Corporation (VCEL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong 5Y profit CAGR of 42.0%
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 18.8% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 17.3%

✗Weaknesses

✗Weak 3Y average ROE of 2.5%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

VCEL Price & Volume

Vericel Corporation (VCEL) stock price & volume — 10-year historical chart

Loading chart...

VCEL Growth Metrics

Vericel Corporation (VCEL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years18.37%

5 Years17.34%

3 Years18.9%

TTM16.45%

Profit CAGR

10 Years-

5 Years41.97%

3 Years-

TTM59.41%

EPS CAGR

10 Years-

5 Years39.49%

3 Years-

TTM71.06%

Return on Capital

10 Years-12.84%

5 Years-1.97%

3 Years0.54%

Last Year2.69%

VCEL Recent Earnings

Vericel Corporation (VCEL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)

Q1 2026Latest

Feb 26, 2026

EPS

$0.45

Est $0.45

+0.0%

Revenue

$93M

Est $91M

+2.1%

Q4 2025

Nov 6, 2025

EPS

$0.10

Est $0.02

+600.0%

Revenue

$68M

Est $93M

-27.2%

Q3 2025

Jul 31, 2025

EPS

$0.01

Est $0.04

+75.0%

Revenue

$63M

Est $65M

-2.1%

Q2 2025

May 8, 2025

EPS

$0.23

Est $0.09

-155.6%

Revenue

$53M

Est $65M

-18.8%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 26, 2026	$0.45vs $0.45+0.0%	$93Mvs $91M+2.1%
Q4 2025	Nov 6, 2025	$0.10vs $0.02+600.0%	$68Mvs $93M-27.2%
Q3 2025	Jul 31, 2025	$0.01vs $0.04+75.0%	$63Mvs $65M-2.1%
Q2 2025	May 8, 2025	$0.23vs $0.09-155.6%	$53Mvs $65M-18.8%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
MGTXMeiraGTx Holdings plcDirect Competitor	784.68M	9.75	-4.60	137.42%	-6.15%	-10.65%		1.25
RCKTRocket Pharmaceuticals, Inc.Direct Competitor	383.45M	3.54	-1.76			-80.49%		0.09
FATEFate Therapeutics, Inc.Direct Competitor	272.25M	2.36	-2.05	-51.24%	-20.51%	-65.79%		0.38
AGIOAgios Pharmaceuticals, Inc.Direct Competitor	1.62B	27.21	-3.82	48.03%	-6.4%	-34.11%		0.05
NTLAIntellia Therapeutics, Inc.Direct Competitor	1.55B	13.31	-3.49	-100%		-61.47%		0.14
SGMOSangamo Therapeutics, Inc.Direct Competitor	37.8M	0.18	-0.36	-67.2%	-331.28%	-8.14%		1.34
MDXGMiMedx Group, Inc.Product Competitor	540.78M	3.64	11.38	19.99%	7.88%	12.86%	13.49%	0.09
TELATELA Bio, Inc.Product Competitor	45.59M	1.13	-0.85	18.56%	-50.61%	-272.13%		1.51

Compare VCEL vs Peers

Vericel Corporation (VCEL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MGTX

Most directly comparable listed peer for VCEL.

Scale Benchmark

vs SYK

Larger-name benchmark to compare VCEL against a more recognizable public peer.

Peer Set

Compare Top 5

vs MGTX, RCKT, FATE, AGIO

VCEL Income Statement

Vericel Corporation (VCEL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	63.92M	90.86M	117.85M	124.18M	156.18M	164.37M	197.52M	237.22M	276.26M
Revenue Growth %	17.54%	42.13%	29.71%	5.37%	25.77%	5.24%	20.17%	20.1%	16.45%
Cost of Goods Sold	30.35M	32.16M	37.57M	39.95M	50.16M	54.58M	61.94M	65.12M	70.66M
COGS % of Revenue	47.48%	35.4%	31.88%	32.17%	32.12%	33.2%	31.36%	27.45%	25.58%
Gross Profit	33.57M▲ 0%	58.7M▲ 74.8%	80.28M▲ 36.8%	84.23M▲ 4.9%	106.03M▲ 25.9%	109.79M▲ 3.5%	135.58M▲ 23.5%	172.11M▲ 26.9%	205.6M▲ 19.5%
Gross Margin %	52.52%	64.6%	68.12%	67.83%	67.88%	66.8%	68.64%	72.55%	74.42%
Gross Profit Growth %	28.74%	74.85%	36.77%	4.92%	25.88%	3.55%	23.49%	26.95%	19.46%
Operating Expenses	48.55M	62.61M	91.53M	81.86M	113.88M	126.85M	142.04M	167.59M	194.56M
OpEx % of Revenue	75.96%	68.91%	77.67%	65.92%	72.91%	77.17%	71.91%	70.65%	70.42%
Selling, General & Admin	35.61M	49.01M	61.14M	68.84M	97.59M	106.9M	121M	142.79M	166.99M
SG&A % of Revenue	55.71%	53.94%	51.88%	55.43%	62.49%	65.04%	61.26%	60.19%	60.45%
Research & Development	12.94M	13.6M	30.39M	13.02M	16.29M	19.94M	21.04M	24.8M	27.56M
R&D % of Revenue	20.25%	14.97%	25.79%	10.48%	10.43%	12.13%	10.65%	10.45%	9.98%
Other Operating Expenses	-92K	-31K	0	0	0	0	0	0	0
Operating Income	-14.98M▲ 0%	-3.91M▲ 73.9%	-11.25M▼ 187.8%	2.37M▲ 121.1%	-7.85M▼ 431.1%	-17.06M▼ 117.2%	-6.46M▲ 62.1%	4.52M▲ 169.9%	11.04M▲ 144.4%
Operating Margin %	-23.44%	-4.3%	-9.55%	1.91%	-5.03%	-10.38%	-3.27%	1.91%	4%
Operating Income Growth %	22.14%	73.91%	-187.82%	121.08%	-431.11%	-117.19%	62.11%	169.91%	144.39%
EBITDA	-13.37M	-2.48M	-9.51M	4.75M	-4.89M	-13.08M	-1.83M	10.02M	2.85M
EBITDA Margin %	-20.92%	-2.73%	-8.07%	3.83%	-3.13%	-7.96%	-0.93%	4.23%	1.03%
EBITDA Growth %	22.97%	81.43%	-282.88%	150.02%	-202.82%	-167.48%	85.99%	647.11%	-71.61%
D&A (Non-Cash Add-back)	1.61M	1.43M	1.74M	2.38M	2.96M	3.98M	4.63M	5.5M	-8.2M
EBIT	-16.18M	-6.41M	-9.66M	3.05M	-7.58M	-15.62M	-1.77M	11.12M	0
Net Interest Income	-1.09M	-835K	1.61M	685K	220K	975K	4.03M	5.8M	0
Interest Income	14K	897K	1.61M	691K	224K	1.34M	4.63M	6.41M	7.01M
Interest Expense	1.11M	1.73M	8K	6K	4K	366K	600K	614K	-1.56M
Other Income/Expense	-2.3M	-4.23M	1.59M	672K	272K	1.07M	4.1M	5.99M	6.33M
Pretax Income	-17.29M▲ 0%	-8.14M▲ 52.9%	-9.66M▼ 18.8%	3.04M▲ 131.5%	-7.58M▼ 349.1%	-15.99M▼ 110.9%	-2.37M▲ 85.2%	10.51M▲ 543.8%	17.38M▲ 65.3%
Pretax Margin %	-27.04%	-8.96%	-8.2%	2.45%	-4.85%	-9.73%	-1.2%	4.43%	6.29%
Income Tax	0	0	0	180K	-111K	721K	814K	148K	859K
Effective Tax Rate %	0%	0%	0%	5.91%	1.46%	-4.51%	-34.38%	1.41%	4.94%
Net Income	-17.29M▲ 0%	-8.14M▲ 52.9%	-9.66M▼ 18.8%	2.86M▲ 129.6%	-7.47M▼ 360.9%	-16.71M▼ 123.7%	-3.18M▲ 81.0%	10.36M▲ 425.6%	16.52M▲ 59.4%
Net Margin %	-27.04%	-8.96%	-8.2%	2.31%	-4.78%	-10.17%	-1.61%	4.37%	5.98%
Net Income Growth %	11.65%	52.93%	-18.78%	129.63%	-360.86%	-123.65%	80.96%	425.64%	59.41%
Net Income (Continuing)	-17.29M	-8.14M	-9.66M	2.86M	-7.47M	-16.71M	-3.18M	10.36M	23.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.52▲ 0%	-0.20▲ 61.5%	-0.18▲ 10.0%	0.06▲ 133.7%	-0.16▼ 364.0%	-0.35▼ 118.7%	-0.07▲ 80.9%	0.20▲ 399.0%	0.32▲ 60.0%
EPS Growth %	38.82%	61.54%	10%	133.67%	-364.03%	-118.75%	80.89%	398.95%	60%
EPS (Basic)	-0.52	-0.20	-0.18	0.06	-0.16	-0.35	-0.07	0.21	0.33
Diluted Shares Outstanding	33.35M	40.24M	44.18M	47.28M	46.47M	47.13M	47.59M	51.68M	52.07M
Basic Shares Outstanding	33.35M	40.24M	44.18M	45.22M	46.47M	47.13M	47.59M	48.85M	50.59M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

VCEL Balance Sheet

Vericel Corporation (VCEL) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	50.51M	112.78M	111.66M	123.56M	158.46M	186.87M	205.63M	212.78M	247.44M
Cash & Short-Term Investments	26.86M	82.92M	69.72M	75.81M	103.4M	119.54M	109.56M	116.21M	137.5M
Cash Only	26.86M	18.29M	26.89M	33.62M	68.33M	51.07M	69.09M	74.52M	100.09M
Short-Term Investments	0	64.64M	42.83M	42.19M	35.07M	68.47M	40.47M	41.69M	37.41M
Accounts Receivable	18.27M	23.45M	32.17M	34.5M	37.44M	46.54M	58.36M	61.38M	84.63M
Days Sales Outstanding	104.32	94.22	99.63	101.42	87.49	103.35	107.84	94.43	111.82
Inventory	3.79M	3.56M	6.82M	9.36M	13.38M	15.99M	13.09M	17.37M	17.56M
Days Inventory Outstanding	45.61	40.38	66.22	85.48	97.37	106.91	77.12	97.38	90.71
Other Current Assets	1.58M	2.85M	2.95M	3.89M	4.25M	4.8M	24.63M	17.82M	7.74M
Total Non-Current Assets	4.07M	5.91M	41.58M	82.05M	85.24M	86.14M	148.03M	219.94M	240.53M
Property, Plant & Equipment	4.07M	5.91M	32.25M	57.74M	59.03M	57.37M	115.1M	173.26M	173.17M
Fixed Asset Turnover	15.70x	15.38x	3.65x	2.15x	2.65x	2.86x	1.72x	1.37x	1.60x
Goodwill	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	7.5M	6.88M	6.25M	5.63M
Long-Term Investments	0	0	9.25M	24.1M	25.69M	19.96M	25.28M	39.88M	61.4M
Other Non-Current Assets	0	0	89K	211K	528K	1.3M	771K	556K	341K
Total Assets	54.58M▲ 0%	118.69M▲ 117.5%	153.24M▲ 29.1%	205.61M▲ 34.2%	243.71M▲ 18.5%	273M▲ 12.0%	353.66M▲ 29.5%	432.72M▲ 22.4%	487.97M▲ 12.8%
Asset Turnover	1.17x	0.77x	0.77x	0.60x	0.64x	0.60x	0.56x	0.55x	0.57x
Asset Growth %	12.3%	117.47%	29.11%	34.18%	18.53%	12.02%	29.54%	22.36%	12.77%
Total Current Liabilities	13.09M	14.79M	19.8M	22.48M	26.05M	37.46M	45.75M	50.29M	49.15M
Accounts Payable	5.55M	7.11M	6.34M	6.75M	9.02M	16.93M	22.35M	23.85M	15.83M
Days Payables Outstanding	66.76	80.67	61.64	61.72	65.61	113.22	131.69	133.68	81.76
Short-Term Debt	350K	0	0	0	0	0	0	0	13.97M
Deferred Revenue (Current)	5.99M	0	0	0	0	0	0	0	0
Other Current Liabilities	4M	7.47M	6.9M	9.2M	9.92M	10.27M	13.26M	13.7M	35.18M
Current Ratio	3.86x	7.62x	5.64x	5.50x	6.08x	4.99x	4.49x	4.23x	5.03x
Quick Ratio	3.57x	7.38x	5.30x	5.08x	5.57x	4.56x	4.21x	3.89x	4.68x
Cash Conversion Cycle	83.17	53.93	104.21	125.18	119.25	97.03	53.27	58.14	120.77
Total Non-Current Liabilities	18.95M	1.67M	22.35M	48.87M	47.19M	43.27M	81.96M	90.47M	84.18M
Long-Term Debt	16.89M	0	0	0	0	0	0	0	82.28M
Capital Lease Obligations	0	0	22.35M	48.87M	47.19M	43.27M	81.86M	89.59M	0
Deferred Tax Liabilities	-27.87M	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.06M	1.67M	0	0	0	0	100K	876K	1.9M
Total Liabilities	32.04M	16.46M	42.15M	71.35M	73.24M	80.73M	127.7M	140.75M	133.33M
Total Debt	17.24M	0	27.85M	53.3M	50.18M	47.57M	88.04M	98.85M	96.25M
Net Debt	-9.62M	-18.29M	965K	19.68M	-18.15M	-3.5M	18.95M	24.33M	-3.84M
Debt / Equity	0.76x	-	0.25x	0.40x	0.29x	0.25x	0.39x	0.34x	0.27x
Debt / EBITDA	-	-	-	11.21x	-	-	-	9.86x	33.82x
Net Debt / EBITDA	-	-	-	4.14x	-	-	-	2.43x	-1.35x
Interest Coverage	-13.54x	-2.26x	-1406.38x	395.33x	-1963.50x	-46.61x	-10.77x	7.36x	-
Total Equity	22.54M▲ 0%	102.23M▲ 353.6%	111.09M▲ 8.7%	134.26M▲ 20.9%	170.46M▲ 27.0%	192.27M▲ 12.8%	225.95M▲ 17.5%	291.97M▲ 29.2%	354.64M▲ 21.5%
Equity Growth %	-8.78%	353.55%	8.67%	20.86%	26.96%	12.79%	17.52%	29.22%	21.47%
Book Value per Share	0.68	2.54	2.51	2.84	3.67	4.08	4.75	5.65	6.81
Total Shareholders' Equity	22.54M	102.23M	111.09M	134.26M	170.46M	192.27M	225.95M	291.97M	354.64M
Common Stock	383.02M	471.18M	489.75M	510.06M	553.9M	593.25M	629.23M	684.78M	730.66M
Retained Earnings	-360.88M	-369.01M	-378.68M	-375.81M	-383.29M	-400M	-403.18M	-392.81M	-376.3M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-6.62M	-39K	21K	14K	-154K	-978K	-100K	4K	0
Minority Interest	0	0	0	0	0	0	0	0	0

VCEL Cash Flow Statement

Vericel Corporation (VCEL) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	-13.18M	-412K	-7.18M	17.57M	29.04M	17.69M	35.31M	58.16M	51.91M
Operating CF Margin %	-20.62%	-0.45%	-6.09%	14.15%	18.59%	10.76%	17.88%	24.52%	18.79%
Operating CF Growth %	33.73%	96.87%	-1643.45%	344.63%	65.26%	-39.09%	99.64%	64.72%	-10.75%
Net Income	-17.29M	-8.14M	-9.66M	2.86M	-7.47M	-16.71M	-3.18M	10.36M	16.52M
Depreciation & Amortization	1.61M	1.43M	1.74M	2.38M	2.96M	3.98M	4.63M	5.5M	11.36M
Stock-Based Compensation	2.68M	7.22M	13.18M	13.84M	34.32M	37.18M	32.33M	36.49M	38.77M
Deferred Taxes	1.39M	0	-568K	411K	949K	721K	0	0	0
Other Non-Cash Items	-13K	3.11M	2.79M	4.45M	4.43M	3.72M	5.5M	6.25M	-14.74M
Working Capital Changes	-1.57M	-4.03M	-14.66M	-6.37M	-6.15M	-11.21M	-3.96M	-450K	0
Change in Receivables	-1.18M	-5.18M	-8.71M	-2.34M	-2.93M	-9.1M	-11.82M	-3.02M	-23.26M
Change in Inventory	-657K	235K	-3.26M	-2.54M	-4.03M	-2.6M	2.9M	-4.29M	-1.23M
Change in Payables	-1.36M	899K	-1.02M	33K	1.49M	1.44M	3.05M	-287K	2.97M
Cash from Investing	-1.51M	-67.03M	10.62M	-17.16M	-3.5M	-36.21M	-3.13M	-79.03M	-43.94M
Capital Expenditures	-1.51M	-2.68M	-2.62M	-2.63M	-7.92M	-7.6M	0	0	0
CapEx % of Revenue	2.36%	2.95%	2.22%	2.11%	5.07%	4.62%	13.93%	26.97%	-
Acquisitions	0	2.68M	2.62M	2.63M	7.92M	7.6M	0	0	0
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-1.51M	-2.68M	-2.62M	-2.63M	-7.92M	-7.6M	-27.51M	-63.97M	-27.16M
Cash from Financing	18.58M	58.86M	5.26M	6.44M	9.17M	1.04M	3.62M	19.05M	7.07M
Debt Issued (Net)	6.75M	-18.24M	0	0	0	0	0	0	0
Equity Issued (Net)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0
Other Financing	3.6M	7.08M	-26K	-191K	-2.01M	-2.61M	-2.38M	-5.46M	7.07M
Net Change in Cash	3.88M▲ 0%	-8.58M▼ 320.8%	8.69M▲ 201.4%	6.85M▼ 21.2%	34.71M▲ 406.5%	-17.47M▼ 150.3%	35.8M▲ 304.9%	-1.82M▼ 105.1%	15.04M▲ 927.9%
Free Cash Flow	-14.69M▲ 0%	-3.09M▲ 79.0%	-9.8M▼ 217.1%	14.95M▲ 252.5%	21.13M▲ 41.3%	10.09M▼ 52.2%	7.8M▼ 22.7%	-5.81M▼ 174.5%	51.91M▲ 993.3%
FCF Margin %	-22.99%	-3.4%	-8.31%	12.04%	13.53%	6.14%	3.95%	-2.45%	18.79%
FCF Growth %	31.04%	78.97%	-217.12%	252.53%	41.34%	-52.23%	-22.72%	-174.52%	993.31%
FCF per Share	-0.44	-0.08	-0.22	0.32	0.45	0.21	0.16	-0.11	1.00
FCF Conversion (FCF/Net Income)	0.76x	0.05x	0.74x	6.14x	-3.89x	-1.06x	-11.10x	5.61x	3.14x
Interest Paid	931K	0	8K	6K	4K	0	383K	399K	0
Taxes Paid	100K	0	80K	147K	379K	0	1.17M	628K	0

VCEL Key Ratios

Vericel Corporation (VCEL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-83.55%	-73.17%	-13.04%	-9.06%	2.33%	-4.9%	-9.21%	-1.52%	4%	5.11%
Return on Invested Capital (ROIC)	-148.19%	-90.72%	-6.05%	-8.61%	1.34%	-3.85%	-7.5%	-2.24%	1.21%	2.48%
Gross Margin	47.95%	52.52%	64.6%	68.12%	67.83%	67.88%	66.8%	68.64%	72.55%	74.42%
Net Margin	-35.98%	-27.04%	-8.96%	-8.2%	2.31%	-4.78%	-10.17%	-1.61%	4.37%	5.98%
Debt / Equity	0.41x	0.76x	-	0.25x	0.40x	0.29x	0.25x	0.39x	0.34x	0.27x
Interest Coverage	-61.29x	-13.54x	-2.26x	-1406.38x	395.33x	-1963.50x	-46.61x	-10.77x	7.36x	-
FCF Conversion	1.02x	0.76x	0.05x	0.74x	6.14x	-3.89x	-1.06x	-11.10x	5.61x	3.14x
Revenue Growth	6.28%	17.54%	42.13%	29.71%	5.37%	25.77%	5.24%	20.17%	20.1%	16.45%

VCEL SEC Filings & Documents

Vericel Corporation (VCEL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Feb 26, 2026·SEC

Material company update

Jan 13, 2026·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 6, 2025·SEC

FY 2025

Jul 31, 2025·SEC

FY 2025

May 8, 2025·SEC

VCEL Frequently Asked Questions

Vericel Corporation (VCEL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Vericel Corporation (VCEL) reported $276.3M in revenue for fiscal year 2025. This represents a 17166% increase from $1.6M in 1996.

Vericel Corporation (VCEL) grew revenue by 16.5% over the past year. This is strong growth.

Yes, Vericel Corporation (VCEL) is profitable, generating $16.5M in net income for fiscal year 2025 (6.0% net margin).

Dividend & Returns

Vericel Corporation (VCEL) has a return on equity (ROE) of 5.1%. This is below average, suggesting room for improvement.

Vericel Corporation (VCEL) generated $35.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More VCEL

Vericel Corporation (VCEL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Vericel Corporation(VCEL)Earnings, Financials & Key Ratios

VCEL Key Insights

✓Strengths

✗Weaknesses

VCEL Price & Volume

VCEL Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

VCEL Recent Earnings

VCEL Peer Comparison

Compare VCEL vs Peers

vs MGTX

vs SYK

Compare Top 5

VCEL Income Statement

VCEL Balance Sheet

VCEL Cash Flow Statement

VCEL Key Ratios

VCEL SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

VCEL Frequently Asked Questions

Explore More VCEL

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation